Institutional Ownership
Recursion Pharmaceuticals In
CUSIP 75629V104CL ARXRXQ1 2026
13D / 13G Filings
34
Schedule 13D/13G on record
Beneficial Filers
15
Distinct reporting persons
Largest Stake
13.9%
Max % of class reported
Institutional Holders
327
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
34 filings · latest Feb 5, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 5, 2026 | Baillie Gifford &Amp; Co | 13G/A | 4.6% | 23.77M | SEC |
| 2 | Feb 3, 2026 | Ark Investment Management LLC | 13G/A | 7.3% | 37.32M | SEC |
| 3 | Dec 23, 2025 | Mubadala Investment Co Pjsc | 13D/A | 1.4% | — | SEC |
| 4 | Apr 4, 2025 | Yohan Kim | 13G | 5.9% | 267.5K | SEC |
| 5 | Feb 14, 2025 | Ra Capital Management, L.P. | 13G/A | 2.0% | 7.73M | SEC |
| 6 | Feb 14, 2025 | Ark Investment Management LLC | 13G/A | 8.5% | 32.35M | SEC |
| 7 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 6.1% | 23.44M | SEC |
| 8 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 8.8% | 24.27M | SEC |
| 9 | Nov 12, 2024 | Fmr LLC | 13G/A | 3.0% | — | SEC |
| 10 | Nov 8, 2024 | Blackrock, Inc. | 13G/A | 7.5% | 20.74M | SEC |
24 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Recursion Pharmaceuticals In.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 43.19M | $132.60M |
| 2 | Ark Investment Management LLC | 40.21M | $123.45M |
| 3 | State Street Corp | 28.49M | $87.47M |
| 4 | Baillie Gifford & Co | 23.68M | $72.68M |
| 5 | Softbank Group Corp. | 13.64M | $41.86M |
| 6 | Geode Capital Management, LLC | 12.28M | $37.69M |
| 7 | Mic Capital Management Uk LLP | 9.64M | $29.61M |
| 8 | Goldman Sachs Group Inc | 6.07M | $18.62M |
| 9 | Data Collective IV Gp, LLC | 5.94M | $18.24M |
| 10 | Lingotto Investment Management LLP | 5.88M | $18.06M |